» Articles » PMID: 1385357

Complement Neoantigen and Vitronectin Are Components of Plaques in Amyloid AL Neuropathy

Overview
Specialty Neurology
Date 1992 Sep 1
PMID 1385357
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

We studied three patients with late onset, chronic sensorimotor and autonomic neuropathy in course of plasma cell dyscrasia with Bence Jones proteinuria. Histopathological findings of nerve biopsies consisted in diffuse loss of myelinated and unmyelinated fibers associated with perivascular deposits of amorphous material with physico-chemical and ultrastructural features of amyloid. By immunohistochemistry, light chains of the same type as Bence Jones protein, components of the classic and lytic pathways of the complement and vitronectin were detected at the level of amyloid nodules. The colocalization of complement neoantigen and vitronectin suggests that this complex derives from the circulation. The elucidation of the chemical composition of amyloid might shed some light in the pathogenesis of these disorders.

Citing Articles

MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits.

Winter M, Tholey A, Kruger S, Schmidt H, Rocken C J Histochem Cytochem. 2015; 63(10):772-9.

PMID: 26101327 PMC: 4823803. DOI: 10.1369/0022155415595264.

References
1.
Kissel J, Halterman R, Rammohan K, Mendell J . The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis. Arch Neurol. 1991; 48(1):26-30. DOI: 10.1001/archneur.1991.00530130034016. View

2.
Young I, Willmer J, Kisilevsky R . The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis. Acta Neuropathol. 1989; 78(2):202-9. DOI: 10.1007/BF00688210. View

3.
Coria F, Castano E, Prelli F, van Duinen S, Shelanski M, Frangione B . Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab Invest. 1988; 58(4):454-8. View

4.
Castano E, Frangione B . Alzheimer's disease from the perspective of the systemic and localized forms of amyloidosis. Brain Pathol. 1991; 1(4):263-71. DOI: 10.1111/j.1750-3639.1991.tb00669.x. View

5.
Glenner G . Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts). N Engl J Med. 1980; 302(24):1333-43. DOI: 10.1056/NEJM198006123022403. View